Cancer is a major cause of morbidity and mortality in dogs, cats, and women worldwide. The ultimate goal for the treatment of malignancies is to eliminate all evidence of cancer, resulting in a cure. With high-grade malignancies, this is usually accomplished with a combination of surgery, chemotherapy, radiation, and, more recently, molecular approaches to cancer therapy. Despite decades of intense effort and billions of dollars of expenditure, cures for high-grade cancers have remained elusive. Fortunately, new knowledge about new and older therapeutic agents, such as the n-3 polyunsaturated fatty acid (PUFAs), docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA) have resulted in improved quality and quantity of life. Many referring veterinarians around the world have noted that medical, surgical, and radiation oncologists are treating with n-3 PUFAs such as DHA to enhance the effects of chemotherapy and radiation therapy and as an adjuvant therapy to prevent cancer progression and metastasis.
展开▼
